Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data

This study used data from the Broad Institute Connectivity Map to perform a comprehensive genomic analysis of the effects of the GHK-Cu complex (glycyl-histidyl-lysine copper) on human gene expression. Researchers identified that GHK-Cu is capable of modulating the expression of more than 4,000 genes, representing about 6% of the human genome, with profound implications for understanding its therapeutic effects.

The analysis revealed that GHK-Cu upregulates genes involved in:

• Tissue repair and wound healing: collagen, fibronectin, integrin, and matrix metalloprotease genes
• Antioxidant defense: superoxide dismutase, catalase, and Nrf2 pathway genes
• Inflammation suppression: reduced expression of IL-6, TNF-α, and other pro-inflammatory cytokines
• Nerve regeneration: neurotrophic factors and myelination genes

A particularly relevant finding was GHK-Cu's ability to suppress genes associated with fibrosis and scar formation, instead promoting true tissue regeneration. This property distinguishes GHK-Cu from many other wound healing agents that may result in excessive fibrosis.

The authors highlighted that the copper ion in the GHK-Cu complex plays an essential role, not only as a cofactor for antioxidant enzymes (such as Cu/Zn superoxide dismutase) but also in the regulation of angiogenesis and collagen synthesis. The study consolidated the view of GHK-Cu as a multifunctional peptide with broad therapeutic potential, from dermatology to neuroprotection.